Treatment of Mesenteric Ischemia
The treatment of mesenteric ischemia requires rapid revascularization with endovascular techniques as first-line therapy for patients without peritoneal signs, while immediate surgical exploration is mandatory for patients with signs of bowel infarction or peritonitis. 1, 2
Diagnostic Approach
- Triple-phase CT angiography is the gold standard for diagnosis, evaluating:
- Arterial filling defects
- Bowel wall changes (thickening, edema, dilation)
- Signs of infarction (pneumatosis, portal venous gas, lack of enhancement)
- Underlying etiology (embolism, thrombosis, venous, non-occlusive)
Treatment Algorithm Based on Type and Severity
Acute Arterial Occlusive Mesenteric Ischemia (Embolic/Thrombotic)
Without Peritoneal Signs or Evidence of Bowel Infarction:
- Immediate systemic anticoagulation with heparin
- Endovascular approach as first-line therapy:
- Aspiration embolectomy for embolic occlusion
- Angioplasty with/without stenting for thrombotic occlusion
- Technical success rates up to 94% 1
- Lower morbidity compared to surgery (less bowel resection, lower renal failure rates)
With Peritoneal Signs or Evidence of Bowel Infarction:
- Immediate surgical exploration is mandatory 1, 2
- Surgical options include:
- Embolectomy
- Bypass grafting
- Retrograde open SMA stenting
- Resection of clearly necrotic bowel
- Damage control principles for borderline ischemic segments
- Mandatory re-exploration within 24-48 hours to reassess bowel viability 2
Nonocclusive Mesenteric Ischemia (NOMI)
- Treat underlying cause (heart failure, shock, vasopressors)
- Angiography with intra-arterial vasodilator therapy:
- Papaverine
- Nitroglycerin
- Prostaglandin E1
- Significantly lower 30-day mortality with vasodilator therapy (65.7%) compared to supportive therapy alone (96.8%) 1
- Time from diagnosis to vasodilator infusion is critical for survival 1
Mesenteric Venous Thrombosis
- Systemic anticoagulation as first-line therapy 1
- Surgical intervention only if signs of bowel infarction develop
Chronic Mesenteric Ischemia
- Endovascular therapy with PTA/stenting as first-line treatment
- Technical success rate 80-100%
- Clinical efficacy 80-95% 3
- Open surgical repair for endovascular failures
- Lower recurrence rates but higher perioperative morbidity 1
Post-Intervention Management
- ICU care focused on improving intestinal perfusion
- Continued anticoagulation therapy
- Careful fluid management and hemodynamic support
- Monitoring for reperfusion syndrome and respiratory distress (reported in 25% of cases) 4
Important Considerations
- Despite advances in treatment, mortality remains high (25-50%) 1, 4
- 70% of patients may still require surgical intervention for bowel resection even after successful endovascular therapy 1
- Advanced age is not a contraindication to aggressive management 2
- Delay in diagnosis is the primary contributor to poor outcomes - maintain high index of suspicion in elderly patients with acute abdominal pain 5
The treatment approach must be tailored to the specific etiology, clinical presentation, and imaging findings, with close collaboration between vascular surgeons, interventional radiologists, and general surgeons 6.